AR103079A1 - PROSTAGLANDINAS EP3 RECEIVER ANTAGONISTS - Google Patents

PROSTAGLANDINAS EP3 RECEIVER ANTAGONISTS

Info

Publication number
AR103079A1
AR103079A1 ARP150104153A ARP150104153A AR103079A1 AR 103079 A1 AR103079 A1 AR 103079A1 AR P150104153 A ARP150104153 A AR P150104153A AR P150104153 A ARP150104153 A AR P150104153A AR 103079 A1 AR103079 A1 AR 103079A1
Authority
AR
Argentina
Prior art keywords
alkyl
prostaglandinas
cycloalkyl
nitrogen
receiver antagonists
Prior art date
Application number
ARP150104153A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR103079A1 publication Critical patent/AR103079A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto de la fórmula (1), en donde m es 1 ó 2; n es 0, 1 ó 2; X e Y son nitrógeno o CR², siempre que, cuando X es nitrógeno, Y sea CR² y también siempre que, cuando X es CR², Y sea nitrógeno; R¹ es H, alquilo C₁₋₆ o cicloalquilo C₃₋₆; R² es H, halógeno, alquilo C₁₋₆ o cicloalquilo C₃₋₆, en donde el alquilo puede estar sustituido con hasta 3 halógenos; y cada R³ es, de modo independiente, halógeno, alquilo C₁₋₆ o cicloalquilo C₃₋₆, en donde alquilo también puede estar sustituido con hasta 3 halógenos; o una de sus sales o solvatos farmacéuticamente aceptables de dicho compuesto o su sal.Claim 1: A compound of the formula (1), wherein m is 1 or 2; n is 0, 1 or 2; X and Y are nitrogen or CR², provided that when X is nitrogen, Y is CR² and also whenever, when X is CR², Y is nitrogen; R¹ is H, C₁₋₆ alkyl or C₃₋₆ cycloalkyl; R² is H, halogen, C₁₋₆ alkyl or C₃₋₆ cycloalkyl, wherein the alkyl may be substituted with up to 3 halogens; and each R³ is independently halogen, C₁₋₆ alkyl or C₃₋₆ cycloalkyl, wherein alkyl may also be substituted with up to 3 halogens; or one of its pharmaceutically acceptable salts or solvates of said compound or its salt.

ARP150104153A 2014-12-22 2015-12-17 PROSTAGLANDINAS EP3 RECEIVER ANTAGONISTS AR103079A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462095337P 2014-12-22 2014-12-22

Publications (1)

Publication Number Publication Date
AR103079A1 true AR103079A1 (en) 2017-04-12

Family

ID=58672208

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150104153A AR103079A1 (en) 2014-12-22 2015-12-17 PROSTAGLANDINAS EP3 RECEIVER ANTAGONISTS

Country Status (1)

Country Link
AR (1) AR103079A1 (en)

Similar Documents

Publication Publication Date Title
CL2016002011A1 (en) Derivatives of condensed bicyclic heterocycles substituted with 2- (het) aryl as agents to fight parasites
EA201692203A1 (en) TANK-BINDING KINAZ INHIBITING COMPOUNDS
EA201790407A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
EA201692219A1 (en) METHODS OF OBTAINING ANTI-VIRUS COMPOUNDS
AR100058A1 (en) RORg MODULATING FUSIONED PYRIMIDIN-PIRAZIN DERIVATIVES
UY36330A (en) TANK UNION QUINASA INHIBITING COMPOUNDS
AR102171A1 (en) SUBSTITUTED COMPOUNDS OF AMINOPURIN, ITS COMPOSITIONS AND ITS USE IN THE TREATMENT OR PREVENTION OF MELANOMA
EA201790627A1 (en) STEMULATORS RHC
EA201791684A1 (en) SELECTIVE BACE1 INHIBITORS
AR106486A1 (en) CGRP RECEIVER ANTAGONISTS
EA201790432A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
CL2017000505A1 (en) Process for the elaboration of derivatives of pyrimidin sulfamide (div. Sol. 2008-2016).
BR112016027691A2 (en) TETRAHYDROPYRIDOPYRIMIDINE COMPOUND AND ITS USES
AR114729A1 (en) ANTIMALARY HEXAHYDROPYRIMIDINE ANALOGUES
EA201890156A1 (en) CGRP RECEPTOR ANTAGONISTS
EA201790400A1 (en) PROBES FOR VISUALIZATION PROTEIN HANTINGTIN
PH12018500903A1 (en) Pyranodipyridine compound
RS54716B1 (en) Heterocyclic compounds and their uses
EA201790687A1 (en) QUINOLINCARBOXAMIDE FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA
EA201791099A1 (en) QUINOLIN CARBOXAMIDE FOR USE IN THE TREATMENT OF LEUKEMIA
AR099880A1 (en) NICOTINAMIDE DERIVATIVES AS TRPA1 MODULATORS
AR106958A1 (en) USEFUL TETRAHYDROTRIAZOLOPIRIMIDINE DERIVATIVES AS HNE INHIBITORS
CL2017000663A1 (en) Use of fluoroalkenyl sulfan heterocyclic compounds to repel mollusks
AR103079A1 (en) PROSTAGLANDINAS EP3 RECEIVER ANTAGONISTS
AR107163A1 (en) QUINASE INHIBITORS

Legal Events

Date Code Title Description
FB Suspension of granting procedure